Choon Yong Loo Buys Handful Of Shares In Raffles Medical Group
Choon Yong Loo Buys Handful Of Shares In Raffles Medical Group
Those following along with Raffles Medical Group Ltd (SGX:BSL) will no doubt be intrigued by the recent purchase of shares by Choon Yong Loo, Executive Chairman & CEO of the company, who spent a stonking S$1.5m on stock at an average price of S$0.89. While that only increased their holding size by 0.7%, it is still a big swing by our standards.
那些关注莱佛士医疗集团有限公司(新加坡交易所:BSL)的人对公司的执行主席兼首席执行官Choon Yong Loo最近购买股票的行为肯定会感到好奇,他以每股平均S$0.89的价格花费了惊人的S$150万购买了股票。尽管这仅仅增加了他们的持股量0.7%,但从我们的标准来看,这仍然是一个很大的变化。
Raffles Medical Group Insider Transactions Over The Last Year
过去一年莱佛士医疗集团的内部交易
Notably, that recent purchase by Executive Chairman & CEO Choon Yong Loo was not the only time they bought Raffles Medical Group shares this year. Earlier in the year, they paid S$1.03 per share in a S$3.6m purchase. That means that an insider was happy to buy shares at above the current price of S$0.91. It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Choon Yong Loo was the only individual insider to buy shares in the last twelve months.
值得注意的是,执行主席兼首席执行官Choon Yong Loo最近一次购买莱佛士医疗集团股票并不是今年他们唯一一次购买。今年早些时候,他们以每股S$1.03的价格进行了一笔S$360万的交易。这意味着一位内部人士愿意以高于当前每股S$0.91的价格购买股票。他们很可能后悔购买,但更有可能他们看好这家公司。对我们来说,考虑内部人员购买股票的价格是非常重要的。作为一般准则,当内部人员以高于当前价格购买股票时,我们对该股持更为积极的看法,因为这表明他们认为该股在更高的价格时仍具有良好的价值。在过去十二个月中,Choon Yong Loo是唯一一位购买股票的个人内部人员。
Choon Yong Loo bought a total of 41.10m shares over the year at an average price of S$0.99. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Choon Yong Loo在一年之内以每股S$0.99的平均价格购买了4110万股股票。您可以在下方看到内部交易(包括公司和个人)在过去12个月中的视觉展示。如果您点击图表,您可以查看所有个人交易,包括股价、个人和日期!
There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).
内部人士正在购买的股票是无数的。如果您喜欢投资于较少知名公司,您可以查看此免费的公司列表(提示:内部人士一直在购买它们)。
Insider Ownership
内部人员持股情况
For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It's great to see that Raffles Medical Group insiders own 15% of the company, worth about S$253m. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
对于一名普通股东来说,值得检查内部人持有多少股份。高比例的内部人持股通常会使公司领导更加关注股东利益。看到莱佛士医疗集团的内部人持有公司15%的股份,价值约25300万新元,这是令人高兴的。大多数股东会乐见这种内部人持股情况,因为这表明管理层的激励与其他股东利益大致一致。
So What Do The Raffles Medical Group Insider Transactions Indicate?
那么,莱佛士医疗集团的内部交易究竟是什么意味着?
It's certainly positive to see the recent insider purchase. And the longer term insider transactions also give us confidence. When combined with notable insider ownership, these factors suggest Raffles Medical Group insiders are well aligned, and quite possibly think the share price is too low. One for the watchlist, at least! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Raffles Medical Group. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Raffles Medical Group.
看到最近的内部人购买当然是积极的。而长期的内部交易也让我们更加有信心。结合显著的内部人持股,这些因素表明莱佛士医疗集团的内部人有很好的一致性,很可能认为股价过低。至少可以将其列入自选名单!除了了解正在进行的内部交易,了解莱佛士医疗集团面临的风险也是有益的。为此,我们发现了1个警示信号,您应该睁大眼睛看一看,以更好地了解莱佛士医疗集团。
Of course Raffles Medical Group may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
当然,莱佛士医疗集团可能不是最好的股票可供购买。因此,您也许希望查看这些优质公司的免费合集。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。